In an effort to make drug development and clinical trials more efficient, life sciences companies and regulatory agencies are demanding higher levels of coordination in trial master file (TMF) processes. Regulatory agencies such as the European Medicines Agency (EMA) and Medicines & Healthcare products Regulatory Agency (MHRA), for example, minimally expect that a company’s TMF…